Prof Lumsden is the Clinical Lead for Reproductive and Maternal Medicine and also, a Consultant Obstetrician and Gynaecologist at the University of Glasgow. She also recently relinquished her position as the Senior Vice President for Strategy at the Royal College of Obstetricians and Gynaecologists in London.
Prof Lumsden has more than 25 years of experience as a senior Clinical Academic in Glasgow where her current research interests include menopause and menstrual disorders as well as chronic disease prevention in women in mid-life. She has published extensively on these topics in peer-reviewed journals. Prof Lumsden also has considerable experience of developing Guidelines. She was Chair of the Guidelines Development Group for the National Institute of Health and Care Excellence (NICE) Guideline ‘Menopause: Investigation and Management’.
In 2017, she was awarded an OBE (Officer of the Order of the British Empire) for Services to Women’s Health, recognising her success in this field.
Prof Lumsden has extensive experience of collaborative projects overseas particularly in South Asia which she visits frequently. She was was International lead for the College of Medical, Veterinary and Life Sciences at the University of Glasgow. She is currently Immediate Past President of the International Menopause Society (2016-2018) and was Vice Chair of the Women’s Health Expert Advisory Group to the Medicine and Hormones Regulatory Authority (2012-2017).
“I share FIGO’s ambition to champion and make major improvements to the health and wellbeing of women and girls, and am delighted to be joining such a prestigious and important organisation for women’s health worldwide,” said Prof. Mary Ann Lumsden.
“We are delighted to be able to appoint someone with such a breadth of experience as Mary Ann to this crucial role, as we prepare to go forward into the next decade.
“We are determined to improve the health of women and girls around the world and will be developing a new strategy to focus our efforts and Mary Ann will play a pivotal role in driving forward major change to increase our influence in more countries,” commented FIGO President Professor Carlos Fuchtner.
FIGO is a non-governmental organisation bringing together professional societies of obstetricians and gynecologists in research, advocacy and clinical best practice. FIGO has a membership base across 132 countries. FIGO was founded on 26 July 1954 in Geneva, Switzerland with a vision that women of the world achieve the highest possible standards of physical, mental, reproductive and sexual health and wellbeing throughout their lives.
For media enquiries, contact: